[CIS PIDD] [cis-pidd] Selective Antibody Deficiency

[CIS-PIDD]

doesnt open.

2017-01-19 15:04 GMT-02:00 CIS-PIDD <cis-pidd at lists.clinimmsoc.org>:

> It is the update and can be found at:  http://www.jacionline.org/
> article/S0091-6749(16)31141-1/fulltext.
>
>
> Sincerely,
>
> Wellington S. Tichenor, M. D.
> 642 Park Avenue
> New York, New York 10065
> 212 517-6611 <(212)%20517-6611>
> wtichenor at sinuses.com <https://register.concentric.com/home/apps/mail/mbox_compose.cgi?pTo=wtichenor@sinuses.com>
>
>
> NOTICE OF CONFIDENTIALITY
> The information contained in this transmission is confidential and may be privileged and/or contain confidential health
> information that is legally protected by state and federal law, including the Health Insurance Portability and Accountability Act of 1996 and related
> regulations.  This information is intended only for the use of the individual or organization to whom it is addressed.  If it is not meant for you, please notify
> the sender immediately by telephone so arrangements may be made to return the documents or destroy them.  Use, disclosure, distribution or copying of
> documents transmitted to you in error is strictly prohibited.  HIPAA regulations suggest that you use encrypted email to send any protected health information.
> Thank you.
>
>
> ------------------------------
> *From:* CIS-PIDD [cis-pidd at lists.clinimmsoc.org]
> *Sent:* Thursday, January 19, 2017 11:27 AM
> *To:* CIS-PIDD
> *Subject:* RE:[cis-pidd] Selective Antibody Deficiency
>
> Is this review different from the update of the uses of human
> immunoglobulins, also to appear in JACI this year?
>
> If different , could you give some details about how to find it?
>
> Ricardo Sorensen
>
>
>
> *From:* CIS-PIDD [mailto:cis-pidd at lists.clinimmsoc.org]
> *Sent:* Tuesday, January 17, 2017 8:01 PM
> *To:* CIS-PIDD
> *Subject:* [cis-pidd] Selective Antibody Deficiency
>
>
>
> **EXTERNAL EMAIL: EVALUATE**
>
> In  2012, the Clinical Immunology Committee of the AAAAI issued a working
> group report published in JACI reclassifying selective antibody deficiency
> into 4 groups, including a mild category, defined as a lack of response to
> 2 or more of the serotypes in the Pneumovax vaccine.  They also stated that
> treatment with replacement Ig might be warranted.
>
> The Primary Immunodeficiency Committee of the AAAAI has just published a
> work group report reiterating the same recommendation.  That report is
> currently available online and will be published in JACI in March 2017.
> With both groups in agreement regarding the potential use of Ig in patients
> with this diagnosis, is there now a consensus that treatment may be
> appropriate in some patients with the mild phenotype?
>
> I recognize that until now, many disagreed with that original suggestion.
> I primarily treat patients with chronic rhinosinusitis which is resistant
> to all treatments including multiple surgeries, culture directed
> antibiotics, omalizumab, etc.  I have had several patients with SAD mild
> phenotype who received a trial of Ig and have responded well to therapy.
> While there may be a limited number of patients who require this treatment,
> it can be very beneficial.
>
> I would appreciate the groups thoughts on this since many insurance
> companies still refuse to authorize treatment under the above circumstances.
>
> Sincerely,
>
>
> Wellington S. Tichenor, MD, FACP, FAAAI
> 642 Park Avenue
> New York, New York 10065
> 212 517-6611 <(212)%20517-6611>
> wtichenor at sinuses.com <https://register.concentric.com/home/apps/mail/mbox_compose.cgi?pTo=wtichenor@sinuses.com>
>
>
>
> NOTICE OF CONFIDENTIALITY
> The information contained in this transmission is confidential and may be privileged and/or contain confidential health
> information that is legally protected by state and federal law, including the Health Insurance Portability and Accountability Act of 1996 and related
> regulations.  This information is intended only for the use of the individual or organization to whom it is addressed.  If it is not meant for you, please notify
> the sender immediately by telephone so arrangements may be made to return the documents or destroy them.  Use, disclosure, distribution or copying of
> documents transmitted to you in error is strictly prohibited.  HIPAA regulations suggest that you use encrypted email to send any protected health information.
> Thank you.
>
> ---
>
> You are currently subscribed to cis-pidd as: rsoren at lsuhsc.edu.
>
> To unsubscribe click here: http://cts.dundee.net/u?id=96396872.
> ade83bbd1f26603d33d3160b249a1880&n=T&l=cis-pidd&o=4132757
>
> (It may be necessary to cut and paste the above URL if the line is broken)
>
> or send a blank email to leave-4132757-96396872.
> ade83bbd1f26603d33d3160b249a1880 at lyris.dundee.net
>
> ---
>
> You are currently subscribed to cis-pidd as: wtichenor at sinuses.com.
>
> To unsubscribe click here: http://cts.dundee.net/u?id=103907632.
> af300b3c63db1eee7c6f4999e9fe98ff&n=T&l=cis-pidd&o=4136204
>
> (It may be necessary to cut and paste the above URL if the line is broken)
>
> or send a blank email to leave-4136204-103907632.
> af300b3c63db1eee7c6f4999e9fe98ff at lyris.dundee.net
>
> ---
>
> You are currently subscribed to cis-pidd as: leonardo.oliveira.mendonca@
> gmail.com.
>
> To unsubscribe click here: http://cts.dundee.net/u?id=96396764.
> 5d5926a8e01f475d7bf6717a52d027f0&n=T&l=cis-pidd&o=4136293
>
> (It may be necessary to cut and paste the above URL if the line is broken)
>
> or send a blank email to leave-4136293-96396764.
> 5d5926a8e01f475d7bf6717a52d027f0 at lyris.dundee.net
>



-- 

Leonardo Oliveira Mendonça
Médico Especialista em Imunologia Clínica e Alergia, Doenças Autoimunes e
Autoinflamatórias
Médico Especialista em Clínica Médica/Medicina Interna

Leonardo Oliveira Mendonça, MD
Specialist in Clinical Immunology and Allergy, Autoimmune and
Autoinflammatory disorders
Consultant Specialist in Internal Medicine

---
You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://cts.dundee.net/u?id=96396833.5a9591ccd1e327fe6bc4d1543298c482&n=T&l=cis-pidd&o=4136404
or send a blank email to leave-4136404-96396833.5a9591ccd1e327fe6bc4d1543298c482 at lyris.dundee.net
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20170119/35d9e636/attachment-0001.html>